GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Orgenesis Inc (FRA:45O0) » Definitions » Future 3-5Y EPS without NRI Growth Rate

Orgenesis (FRA:45O0) Future 3-5Y EPS without NRI Growth Rate : N/A (As of May. 19, 2025)


View and export this data going back to 2020. Start your Free Trial

What is Orgenesis Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, Orgenesis's Future 3-5Y EPS without NRI Growth Rate is N/A.

Competitive Comparison of Orgenesis's Future 3-5Y EPS without NRI Growth Rate

For the Biotechnology subindustry, Orgenesis's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Orgenesis's Future 3-5Y EPS without NRI Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Orgenesis's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Orgenesis's Future 3-5Y EPS without NRI Growth Rate falls into.


;
;

Orgenesis  (FRA:45O0) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

Orgenesis Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Orgenesis's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Orgenesis Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Orgenesis Inc (FRA:45O0) » Definitions » Future 3-5Y EPS without NRI Growth Rate
Comparable Companies
CLCS NERV RLYB HOTH IMNN BRTX ATHA NXTC ICU DWTX VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
ORGS:USA
Address
20271 Goldenrod Lane, Germantown, MD, USA, 20876
Website
https://www.orgenesis.com
Orgenesis Inc is a biotech company working to unlock the potential of cell and gene therapies. It is focused on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient for treatment of the patient at the point of care (POCare). The Company's business includes two reporting segments: Octomera and Therapies.

Orgenesis Headlines

No Headlines